Radiation Therapy Toxicity to the Skin

Dermatologic Clinics

Volumn 26, Issue 1, 2008, Pages 161-172

  FitzGerald, T J ^a   Jodoin, Maryann Bishop ^a   Tillman, Gayle ^a   Aronowitz, Jesse ^a   Pieters, Richard ^a   Balducci, Susan ^a   Meyer, Joshua ^a   Cicchetti, M Giulia ^a   Kadish, Sidney ^a   McCauley, Shelagh ^a   Sawicka, Joanna ^a   Urie, Marcia ^a   Lo, Y C ^a   Mayo, Charles ^a   Ulin, Kenneth ^a   Ding, Linda ^a   Britton, Maureen ^a   Huang, Jiayi ^a   Arous, Edward ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; BLEOMYCIN; CAPECITABINE; CEFOTETAN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACARBAZINE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; EDATREXATE; ETOPOSIDE; FLUOROURACIL; GATIFLOXACIN; GEMCITABINE; HYDROCORTISONE; HYDROXYUREA; MELPHALAN; METHOTREXATE; MITOXANTRONE; OXALIPLATIN; PACLITAXEL; PHENTERMINE; SIMVASTATIN; TAMOXIFEN; VINBLASTINE;

BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; HUMAN; NEUROIMAGING; PATIENT CARE; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOBIOLOGY; RELAPSE; REVIEW; SCLERODERMA; SKIN CARE; SKIN TOXICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; RADIOTHERAPY; SKIN; SKIN CARE; SKIN NEOPLASMS;

EID: 36048954801     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.08.005     Document Type: Review

References (45)

1. Rubin P., and Casarett G. Clinical radiation pathology, vol. 2 (1968), WB Saunders, Philadelphia
2. Farjardo L., Berthrong M., and Anderson R. Radiation pathology-skin (2001), Oxford University Press, New York p. 411-20
3. Cleaver J. Defective repair of replication of DNA in xeroderma pigmentosum. Nature 218 (1968) 652-656
4. Anderson D., Taylor W., Falls H., et al. The nevoid basal cell carcinoma syndrome. Am J Hum Genet 19 (1967) 19-29
5. Cox J.D., and Ang K.K. Radiation oncology: rationale-technique-results. 8th edition (2003), Mosby, St. Louis (MO) p. 127-43
6. Hall E., and Giaccia A. Radiobiology for the radiologist. 6th edition (2006), Lippincott Williams &Wilkins, Philadelphia p. 47-105
7. Matanoski G., Seltser P., Sartwell P., et al. The current mortality rates of radiologists and other physician specialists: specific causes of death. Am J Epidemiol 101 (1975) 199-210
8. Halperin E., Constine L., Tarbell N., et al. Pediatric radiation oncology. 4th edition (2005), Lippencott Williams & Wilkins, Philadelphia p. 514-5
9. Lo Y.C., Yasuda G., Fitzgerald T.J., et al. Intensity modulation for breast treatment using static multi-leaf collimators. Int J Radiat Oncol Biol Phys 46 1 (2000) 187-194
10. Mayo C.S., Urie M.M., and Fitzgerald T.J. Hybrid IMRT plans-concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. Int J Radiat Oncol Biol Phys 61 3 (2005) 922-932
11. Aristizabal S.A., Miller R.C., Schlichtemeier A.L., et al. Adriamycin-irradiation cutaneous complications. Int J Radiat Oncol Biol Phys 2 3-4 (1977) 325-331
12. Greco F.A., Brereton H.D., and Kent H. Adriamycin and enhanced radiation reaction in normal esophagus and skin. Ann Intern Med 85 3 (1975) 294-298
13. Putnik K., Stadler C., and Koelbl O. Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy-case report and review of literature. Radiat Oncol 1 (2006) 32
14. D'Angio G.J., Farber S., and Maddock C.L. Potentiation of x-ray effects by actinomycin-D. Radiology 73 (1959) 175-177
15. Toledano A., Garaud P., Serin D., et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. Int J Radiat Biol Phys 65 2 (2006) 324-332
16. Dubey A., Recht A., Come S.E., et al. Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study. Int J Radiat Oncol Biol Phys 45 4 (1999) 877-884
17. Vassilios E., Kouloulias J.R., Kouvaris J.D., et al. Impact on cytoprotective efficacy of intermediate interval between amifostine administration and radiotherapy: a retrospective analysis. Int J Radiat Oncol Biol Phys 59 4 (2004) 1148-1156
18. Lin L.C., Que J., Lin L.K., et al. Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study. Int J Radiat Oncol Biol Phys 65 3 (2006) 745-750
19. Xiao Z., Su Y., Yang S., et al. Protective effect of esculentoside A on radiation-induced dermatitis and fibrosis. Int J Radiat Oncol Biol Phys 65 3 (2006) 882-889
20. Boström A., Lindman H., Swartling C., et al. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol 59 3 (2001) 257-265
21. Kouvaris J.R., Kouloulias V.E., Plataniotis G.A., et al. Dermatitis during radiation for vulvar carcinoma: prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze. Wound Repair Regen 9 3 (2001) 187-193
22. Ristić B. Radiation recall dermatitis. Int J Dermatol 43 9 (2004) 627-631
23. Azria D., Magné N., Zouhair A., et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev 31 7 (2005) 555-570
24. Morris M., and Powell S. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 15 7 (1997) 2728-2735
25. Ayoola A., and Lee Y.J. Recall dermatitis with cefotetan: a case study. Oncologist 11 10 (2006) 1118-1120
26. Kang S.K. Images in clinical medicine. Radiation recall reaction after antimicrobial therapy. N Engl J Med 354 6 (2006) 622
27. Singer E.A., Warren R.D., Pennanen M.F., et al. Tamoxifen-induced radiation recall dermatitis. Breast J 10 2 (2004) 170-171
28. Ash R.B., and Videtic G.M. Radiation recall dermatitis after the use of the anorexia phentermine in a patient with breast cancer. Breast J 12 2 (2006) 186-187
29. Scodan R.L., Wyplosz B., Couchon S., et al. UV-light induced radiation recall dermatitis after a chemoradiotherapy organ preservation protocol. Eur Arch Otorhinolaryngol 264 9 (2007) 1099-1102
30. Abadir R., and Liebmann J. Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol (R Coll Radiol) 7 5 (1995) 325-326
31. Gold D., Miller R., Peterson I., et al. Radiotherapy for malignancy in patients with scleroderma: the Mayo clinic experience. Int J Radiat Oncol Biol Phys 67 2 (2007) 559-567
32. Chen A., Obedian E., Hafty B., et al. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J 7 6 (2001) 475-476
33. Ross J., Hussey D., Mayr N., et al. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer 71 11 (1993) 3744-3752
34. Phan C., Mindrum M., Silverman M., et al. Matched-control retrospective study of the active and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J 9 6 (2003) 461-466
35. Ron E., Preston D.L., Mabuschi K., et al. Skin tumor risk among atomic-bomb survivors in Japan. Cancer Causes Control 9 (1998) 393-401
36. Ron E., Modan B., Preston D., et al. Radiation-induced skin carcinomas of the head and neck. Radiat Res 125 (1991) 318-325
37. Shore R.E. Radiation-induced skin cancer in humans. Med Pediatr Oncol 36 (2001) 549-554
38. Olsen J.H., Garwicz S., Hertz H., et al. Second malignant neoplasms after cancer in childhood or adolescence. Br Med J 307 (1993) 1030-1036
39. Boice J.D., Day N., Andersen A., et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 74 (1985) 955-975
40. Wong F.L., Boice J.D., Abramson D., et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA 278 (1997) 1262-1267
41. Van Leewen F.E., Klokman W.J., van't Veer M.B., et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18 (2000) 487-497
42. Baird E.A., McHenry P.M., and Mackie R.M. Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi. Br Med J 305 (1992) 799-801
43. Metayer C, Lynch CF, Clarke A, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435-43.
44. De la Luz Orozco-Cavarrubias M., Tamoyo-Sanchez L., Duran -McKinster C., et al. Malignant cutaneous tumors in children: twenty years of experience in a large pediatric hospital. J Am Acad Dermatol 30 (1994) 243-249
45. Bruner D., Haas M., and Gosselin-Acomg T. Radiation oncology nursing practice and education. 3rd edition (2005), Oncology Nursing Society (ONS), Pittsburgh